Evaluation of the anticancer effects exerted by 5-fluorouracil and heme oxygenase-1 inhibitor hybrids in HTC116 colorectal cancer cells

AbstractColon cancer remains a clinical challenge in industrialised countries. Its treatment with 5-Flurouracil (5-FU) develops many side effects and resistance. Thus, several strategies have been undertaken so far, including the use of drug cocktails and polypharmacology. Heme oxygenase-1 (HO-1) is...

Full description

Bibliographic Details
Main Authors: Loredana Salerno, Antonietta Notaro, Valeria Consoli, Federica Affranchi, Valeria Pittalà, Valeria Sorrenti, Luca Vanella, Michela Giuliano, Sebastiano Intagliata
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Journal of Enzyme Inhibition and Medicinal Chemistry
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/14756366.2024.2337191
_version_ 1797201667791257600
author Loredana Salerno
Antonietta Notaro
Valeria Consoli
Federica Affranchi
Valeria Pittalà
Valeria Sorrenti
Luca Vanella
Michela Giuliano
Sebastiano Intagliata
author_facet Loredana Salerno
Antonietta Notaro
Valeria Consoli
Federica Affranchi
Valeria Pittalà
Valeria Sorrenti
Luca Vanella
Michela Giuliano
Sebastiano Intagliata
author_sort Loredana Salerno
collection DOAJ
description AbstractColon cancer remains a clinical challenge in industrialised countries. Its treatment with 5-Flurouracil (5-FU) develops many side effects and resistance. Thus, several strategies have been undertaken so far, including the use of drug cocktails and polypharmacology. Heme oxygenase-1 (HO-1) is an emerging molecular target in the treatment of various cancers. We recently demonstrated that a combination of HO-1 inhibitors with 5-FU and the corresponding hybrids SI1/17, SI1/20, and SI1/22, possessed anticancer activity against prostate and lung cancer cells. In this work, we evaluated these hybrids in a model of colon cancer and found that SI1/22 and the respective combo have greater potency than 5-FU. Particularly, compounds inhibit HO-1 activity in cell lysates, increase ROS and the expression of HO-1, SOD, and Nrf2. Moreover, we observed a decrease of pro-caspase and an increase in cleaved PARP-1 and p62, suggesting apoptotic and autophagic cell death and potential application of these drugs as anticancer agents.
first_indexed 2024-04-24T07:51:11Z
format Article
id doaj.art-7cbdfd4d092d43a08cfd45bb07e543c4
institution Directory Open Access Journal
issn 1475-6366
1475-6374
language English
last_indexed 2024-04-24T07:51:11Z
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series Journal of Enzyme Inhibition and Medicinal Chemistry
spelling doaj.art-7cbdfd4d092d43a08cfd45bb07e543c42024-04-18T12:17:19ZengTaylor & Francis GroupJournal of Enzyme Inhibition and Medicinal Chemistry1475-63661475-63742024-12-0139110.1080/14756366.2024.2337191Evaluation of the anticancer effects exerted by 5-fluorouracil and heme oxygenase-1 inhibitor hybrids in HTC116 colorectal cancer cellsLoredana Salerno0Antonietta Notaro1Valeria Consoli2Federica Affranchi3Valeria Pittalà4Valeria Sorrenti5Luca Vanella6Michela Giuliano7Sebastiano Intagliata8Department of Drug and Health Sciences, University of Catania, Catania, ItalyDepartment of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Palermo, ItalyDepartment of Drug and Health Sciences, University of Catania, Catania, ItalyDepartment of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Palermo, ItalyDepartment of Drug and Health Sciences, University of Catania, Catania, ItalyDepartment of Drug and Health Sciences, University of Catania, Catania, ItalyDepartment of Drug and Health Sciences, University of Catania, Catania, ItalyDepartment of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Palermo, ItalyDepartment of Drug and Health Sciences, University of Catania, Catania, ItalyAbstractColon cancer remains a clinical challenge in industrialised countries. Its treatment with 5-Flurouracil (5-FU) develops many side effects and resistance. Thus, several strategies have been undertaken so far, including the use of drug cocktails and polypharmacology. Heme oxygenase-1 (HO-1) is an emerging molecular target in the treatment of various cancers. We recently demonstrated that a combination of HO-1 inhibitors with 5-FU and the corresponding hybrids SI1/17, SI1/20, and SI1/22, possessed anticancer activity against prostate and lung cancer cells. In this work, we evaluated these hybrids in a model of colon cancer and found that SI1/22 and the respective combo have greater potency than 5-FU. Particularly, compounds inhibit HO-1 activity in cell lysates, increase ROS and the expression of HO-1, SOD, and Nrf2. Moreover, we observed a decrease of pro-caspase and an increase in cleaved PARP-1 and p62, suggesting apoptotic and autophagic cell death and potential application of these drugs as anticancer agents.https://www.tandfonline.com/doi/10.1080/14756366.2024.2337191Hybridsmutual prodrugs5-fluorouracilheme oxygenase 1HTC116 colorectal cancer cells
spellingShingle Loredana Salerno
Antonietta Notaro
Valeria Consoli
Federica Affranchi
Valeria Pittalà
Valeria Sorrenti
Luca Vanella
Michela Giuliano
Sebastiano Intagliata
Evaluation of the anticancer effects exerted by 5-fluorouracil and heme oxygenase-1 inhibitor hybrids in HTC116 colorectal cancer cells
Journal of Enzyme Inhibition and Medicinal Chemistry
Hybrids
mutual prodrugs
5-fluorouracil
heme oxygenase 1
HTC116 colorectal cancer cells
title Evaluation of the anticancer effects exerted by 5-fluorouracil and heme oxygenase-1 inhibitor hybrids in HTC116 colorectal cancer cells
title_full Evaluation of the anticancer effects exerted by 5-fluorouracil and heme oxygenase-1 inhibitor hybrids in HTC116 colorectal cancer cells
title_fullStr Evaluation of the anticancer effects exerted by 5-fluorouracil and heme oxygenase-1 inhibitor hybrids in HTC116 colorectal cancer cells
title_full_unstemmed Evaluation of the anticancer effects exerted by 5-fluorouracil and heme oxygenase-1 inhibitor hybrids in HTC116 colorectal cancer cells
title_short Evaluation of the anticancer effects exerted by 5-fluorouracil and heme oxygenase-1 inhibitor hybrids in HTC116 colorectal cancer cells
title_sort evaluation of the anticancer effects exerted by 5 fluorouracil and heme oxygenase 1 inhibitor hybrids in htc116 colorectal cancer cells
topic Hybrids
mutual prodrugs
5-fluorouracil
heme oxygenase 1
HTC116 colorectal cancer cells
url https://www.tandfonline.com/doi/10.1080/14756366.2024.2337191
work_keys_str_mv AT loredanasalerno evaluationoftheanticancereffectsexertedby5fluorouracilandhemeoxygenase1inhibitorhybridsinhtc116colorectalcancercells
AT antoniettanotaro evaluationoftheanticancereffectsexertedby5fluorouracilandhemeoxygenase1inhibitorhybridsinhtc116colorectalcancercells
AT valeriaconsoli evaluationoftheanticancereffectsexertedby5fluorouracilandhemeoxygenase1inhibitorhybridsinhtc116colorectalcancercells
AT federicaaffranchi evaluationoftheanticancereffectsexertedby5fluorouracilandhemeoxygenase1inhibitorhybridsinhtc116colorectalcancercells
AT valeriapittala evaluationoftheanticancereffectsexertedby5fluorouracilandhemeoxygenase1inhibitorhybridsinhtc116colorectalcancercells
AT valeriasorrenti evaluationoftheanticancereffectsexertedby5fluorouracilandhemeoxygenase1inhibitorhybridsinhtc116colorectalcancercells
AT lucavanella evaluationoftheanticancereffectsexertedby5fluorouracilandhemeoxygenase1inhibitorhybridsinhtc116colorectalcancercells
AT michelagiuliano evaluationoftheanticancereffectsexertedby5fluorouracilandhemeoxygenase1inhibitorhybridsinhtc116colorectalcancercells
AT sebastianointagliata evaluationoftheanticancereffectsexertedby5fluorouracilandhemeoxygenase1inhibitorhybridsinhtc116colorectalcancercells